xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE

ACT OF 1934

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE

ACT OF 1934

110 Spring Hill Road #10

Grass Valley, CA95945

(Address of principal executive offices)

~~(530)~~ (530) 802-5023

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

As of ~~May 5, 2021,~~April 27, 2022, there were ~~4,635,222,744~~12,803,231,651 shares of the registrant’s $0.001 par value common stock issued and outstanding.

Statements made in this Form 10-Q that are not historical or current facts are “forward-looking statements.”. These statements often can be identified by the use of terms such as “may,” “will,” “expect,” “believe,” “anticipate,” “estimate,” “approximate” or “continue,” or the negative thereof. We intend that such forward-looking statements be subject to the safe harbors for such statements. We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. Any forward-looking statements represent management’s best judgment as to what may occur in the future. However, forward-looking statements are subject to risks, uncertainties and important factors beyond our control that could cause actual results and events to differ materially from historical results of operations and events and those presently anticipated or projected. We disclaim any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statement or to reflect the occurrence of anticipated or unanticipated events.

The accompanying unaudited financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions for Form 10-Q and Article 210 8-03 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All such adjustments are of a normal recurring nature. Operating results for the three months ended March 31, ~~2021,~~2022, are not necessarily indicative of the results that may be expected for the year ending December 31, ~~2021.~~2022. For further information, refer to the financial statements and footnotes thereto included in our company’s Annual Report on Form 10-K for the year ended December 31, ~~2020~~2021 as filed with the Securities and Exchange Commission on March 31, ~~2021.~~2022.

	March 31,			December 31,
	2021			2020			March 31,			December 31,
	(Unaudited)			(Audited)			2022			2021
ASSETS							(unaudited)			(audited)
Current Assets
Cash	$	379,857		$	72,764		$	73,240		$	219,183
Accounts receivable		910,338			97,701			26,773			3,495
Earnings in excess of billings		238,247			489			1,053,696			880,494
Inventory		68,478			44,223			162,908			147,859
Prepaid expenses		9,811			8,552			8,805			48,217
Other current assets								19,500			19,500
Total current assets		1,606,731			223,729			1,344,922			1,318,748

Property, plant, and equipment, net		112,210			109,339			232,883			249,208
Intangibles, net								475,000			500,000
Right-of-use asset		236,494			246,968			192,787			203,991
Security deposit		16,980			16,980			16,980			16,980
Other assets								85,305			85,305

TOTAL ASSETS	$	1,972,415		$	597,016		$	2,347,877		$	2,374,232

LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current Liabilities:
Accounts payable	$	780,169		$	843,882		$	568,401		$	640,428
Accrued interest		120,235			106,639			229,646			206,806
Accrued liabilities		227,932			286,997			115,250			119,090
Billings in excess of revenue		1,530,671			71,280			1,518,587			1,104,923
Current operating lease liabilities		43,707			42,977			46,750			45,970
Convertible notes payable, net of discount		152,333			149,988			917,323			910,062
Derivative liabilities		1,935,295			2,373,176			336,167			882,706
Liability for unissued shares		150,825			150,825			150,825			150,825
Promissory notes payable, net of discount		216,716			101,056			213,363			205,815
Related party liabilities		200,836			154,252			155,966			138,029
Total Current Liabilities		5,358,719			4,281,072			4,252,278			4,404,654

Long term debt		283,119			281,357			154,199			152,390
Non-current operating lease liabilities		192,787			203,991			146,037			158,021

Total Liabilities		5,834,625			4,766,420			4,552,514			4,715,065

�� Series A convertible preferred stock: $0.001 par value; 30,000,000 shares authorized 1,363,497 shares issued and outstanding at March 31, 2022 1,329,717 shares issued and outstanding at December 31, 2021								13,634,970			13,297,170
Convertible preferred stock payable								150,000			500,000

Commitments and contingencies		—			—			—			—

Stockholders’ Deficit:
Preferred stock, Series A: $0.001 par value; 30,000,000 shares authorized		958			1,120
957,500 shares issued and outstanding at March 31, 2021
1,120,000 shares issued and outstanding at December 31, 2020
Preferred stock, Series B: $0.001 par value; 1,000 shares authorized		1			1
1,000 shares issued and outstanding at March 31, 2021
1,000 shares issued and outstanding at December 31, 2020
Common stock, $0.001 par value; 20,000,000,000 authorized		4,351,431			3,534,022
4,351,431,054 shares issued and outstanding at March 31, 2021
3,534,022,455 shares issued and outstanding at December 31, 2020
Preferred stock, Series B: $0.001 par value; 1,000 shares authorized 1,000 shares issued and outstanding at March 31, 2022 1,000 shares issued and outstanding at December 31, 2021								1			1
Common stock, $0.001 par value; 25,000,000,000 authorized 12,803,231,651 shares issued and outstanding at March 31, 2022 8,109,531,693 shares issued and outstanding at December 31, 2021								12,803,232			8,109,532
Additional paid in capital		1,379,451			(748,254	)		(8,065,349	)		(5,594,134	)
Retained earnings		(9,594,051	)		(6,956,293	)		(20,727,491	)		(18,653,402	)
Total stockholders’ deficit		(3,862,210	)		(4,169,404	)		(15,989,607	)		(16,138,003	)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT	$	1,972,415		$	597,016		$	2,347,877		$	2,374,232


																										Convertible Preferred Stock									Preferred Stock								Additional			Retained			Total
																										Series A						Shares			Series B				Common Stock				Paid-In			Earnings			Shareholders’
																										Shares			Amount			Payable			Shares		Amount		Shares		Amount		Capital			(Deficit)			Equity
Balance at December 31, 2021																											1,329,717		$	13,297,170		$	500,000			1,000	$	1		8,109,531,693	$	8,109,532	$	(5,594,134	)	$	(18,653,402	)	$	(16,138,003	)
Conversion of convertible notes payable to stock																											—			—			—			—		—		3,784,719,901		3,784,720		(2,442,704	)		—			1,342,016
Derivative settlements																											—			—			—			—		—		—		—		521,712			—			521,712
Preferred stock converted to common stock																											(23,720	)		(237,200	)		—			—		—		908,980,057		908,980		(550,223	)		—			358,757
Preferred stock issued for services																											7,500			75,000			—			—		—		—		—		—			—			—
Preferred stock payable converted to convertible preferred stock																											50,000			500,000			(500,000	)		—		—		—		—		—			—			—
Preferred shares to be issued for services																											—			—			150,000			—		—		—		—		—			—			—
Net loss																											—			—			—			—		—		—		—		—			(2,074,089	)		(2,074,089	)
Balance at March 31, 2022																											1,363,497		$	13,634,970		$	150,000			1,000	$	1		12,803,231,651	$	12,803,232	$	(8,065,349	)	$	(20,727,491	)	$	(15,989,607	)

	Preferred Stock						Preferred Stock										Additional						Total			Convertible Preferred Stock									Preferred Stock								Additional			Retained			Total
	Series A						Series B				Common Stock						Paid-In			Retained			Stockholders’			Series A						Shares			Series B				Common Stock				Paid-In			Earnings			Shareholders’
	Shares			Amount			Shares		Amount		Shares			Amount			Capital			Earnings			Equity (Deficit)			Shares			Amount			Payable			Shares		Amount		Shares		Amount		Capital			(Deficit)			Equity
Balance at December 31, 2020		1,120,000		$	1,120			1,000	$	1		3,534,022,455		$	3,534,022		$	(748,254	)	$	(6,956,293	)	$	(4,169,404	)		1,120,000		$	11,200,000		$	—			1,000	$	1		3,534,022,455	$	3,534,022	$	(11,947,134	)	$	(6,956,293	)	$	(15,369,404	)
Conversion of promissory notes to stock		—			—			—		—		175,060,588			175,061			1,448,275			—			1,623,336			—			—			—			—		—		175,060,588		175,061		1,448,275			—			1,623,336
Derivative settlements		—			—			—		—		—			—			435,301			—			435,301			—			—			—			—		—		—		—		435,301			—			435,301
Preferred stock converted to common stock		(172,500	)		(172	)		—		—		570,299,494			570,299			216,188			—			786,315			(172,500	)		(1,725,000	)		—			—		—		570,299,494		570,299		1,941,016			—			2,511,315
Preferred stock issued for services		10,000			10			—		—		—			—			99,990			—			100,000			10,000			100,000			—			—		—		—		—		—			—			—
Warrant exercise		—			—			—		—		72,048,517			72,049			(72,049	)		—			—			—			—			—			—		—		72,048,517		72,049		(72,049	)		—			—
Net loss		—			—			—		—		—			—			—			(2,637,758	)		(2,637,758	)		—			—			—			—		—		—		—		—			(2,637,758	)		(2,637,758	)
Balance at March 31, 2021		957,500		$	958			1,000	$	1		4,351,431,054		$	4,351,431		$	1,379,451		$	(9,594,051	)	$	(3,862,210	)		957,500		$	9,575,000		$	—			1,000	$	1		4,351,431,054	$	4,351,431	$	(8,194,591	)	$	(9,594,051	)	$	(13,437,210	)

	Preferred Stock						Preferred Stock										Additional						Total
	Series A						Series B				Common Stock						Paid-In			Retained			Stockholders’
	Shares			Amount			Shares		Amount		Shares			Amount			Capital			Earnings			Equity (Deficit)
Balance at December 31, 2019		400,000		$	400			1,000	$	—		10,343,330		$	10,343		$	(15,240,774	)	$	9,368,557		$	(5,861,474	)
Conversion of promissory notes to stock		—			—			—		—		32,260,676			32,261			366,617			—			398,878
Derivative settlements		—			—			—		—		—			—			(50,586	)		—			(50,586	)
Cancellation of stock issued for services		—			—			—		—		(8,008,334	)		(8,008	)		(42,257	)		—			(50,265	)
Preferred stock issued per agreement		500,000			500			—		—		—			—			—			—			500
Net loss		—			—			—		—		—			—			—			(2,136,389	)		(2,136,389	)
Balance at March 31, 2020		900,000		$	900			1,000	$	—		34,595,672		$	34,596		$	(14,967,000	)	$	7,232,168		$	(7,699,336	)

~~NOTE~~ 1 – BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Located in Grass Valley, CA, BrewBilt is one of the only California companies that custom designs, hand crafts, and integrates ~~processing,~~brewing, fermentation and ~~distillation processing~~distilling systems for the craft beer ~~cannabis and hemp industries~~industry using “Best in Class” American made ~~components integrated with~~ stainless ~~steel processing vessels using only American made~~ steel. Founded ~~in 2014, the company began in a backyard shop~~ by Jeff Lewis in 2014 with a vision of creating a profitable company ~~in “Rural America”~~ by hiring excellent ~~personnel,~~local craftsmen, designing and ~~fabricating~~building products to exceed ~~customer’s~~customers’ expectations ~~and compensating craftsmen with living wages and profit sharing to financially sustain their families within the community.~~ Mr. Lewis now has ~~15+~~over 20 years of experience as a craft beer brewer, a custom tank/vessel designer, fabrication and integration expert and business owner who initially founded Portland Kettle ~~Works, a nationally recognized manufacturer of craft beer brewing equipment located in the Northwest. The Company has grown from 3 employees in 2015 to 7 in 2021.~~Works.

BrewBilt has ~~been built by having~~ strong relationships with ~~local~~ suppliers of raw materials, equipment, and services globally, in ~~California,~~addition an aggressive referral network of satisfied customers ~~nationwide, and an~~nationwide. An Advisory Board consisting of successful business leaders that provide valuable product feedback and business expertise to management. The craft brewing & spirits industries continue to grow worldwide. California is where craft brewing began and now has over ~~900~~950 operating breweries – being centrally located in this booming market was a large draw for BrewBilt to locate its manufacturing facility in the Sierra foothills.

All BrewBilt products are designed and fabricated as “food grade” quality which enables the company to build vessels for food &and beverage processing , the company is now building systems that are pharmaceutical grade for clients involved in distillation for the cannabis and hemp industries, thus making the revenue potential much greater.processing. BrewBilt buys materials and components mostly from ~~California~~ suppliers which enables ~~them~~BrewBilt to closely monitor quality, while the company’s revenues are generated from sales to customers throughout the country. The company is aggressively pursuing international orders and has held meetings with the Center for International Trade Development and U.S. Commercial Service to develop international opportunities. Presently,world a great deal of ~~sales~~specific interest in coming from Mexico, Japan, Europe, and Australia.

BrewBilt competes against a number of companies, most of which are selling mass produced equipment from China made from less costly inferior quality Chinese steel which often is neither food nor pharmaceutical grade quality. While this broader market is extremely competitive, there continues to be little competition and strong market demand for higher quality, custom designed, hand crafted and integrated systems that BrewBilt produces.

In July of 2016, BrewBilt moved from the small facility in Nevada City, CA to lease an eight thousand (8,000) square foot manufacturing facility in Grass Valley, CA. This facility was purchased by BrewBilt in January 2018 and upgraded with substantial tenant improvements. BrewBilt ~~is prepared to expand again by leasing an additional seventy-six hundred (7,600) square feet in the same facility. BrewBilt~~ obtains the majority of its leads through customer referrals and from online marketplaces. The company’s website ~~is being~~has expanded ~~for~~to include online sales ~~to include~~and online educational/marketing videos that feature the company and its expanded ~~integrated~~ product line ~~for the cannabis and hemp industries.~~of brewing accessories. BrewBilt has also created distribution sales agreements with individuals and companies to represent BrewBilt in both the domestic and international markets.

The Company’s previously issued financial statements for the three months ended March 31, 2021, as included in its Form 10-Q filed on May 14, 2021, have been restated since the Company improperly classified the Series A preferred stock in permanent equity as opposed to liability pursuant to ASC 480-10-25-14(A), since the financial instrument embodies an unconditional obligation to transfer a variable number of shares and the monetary value of such obligation is based solely on a fixed amount known at inception.

The audited financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”).

As per ASC 805-50 a common-control transaction does not meet the definition of a business combination because there is no change in control over the net assets. The accounting for these transactions is addressed in the “Transactions Between Entities Under Common Control”. The net assets are derecognized by the transferring entity and recognized by the receiving entity at the historical cost of the parent of the entities under common control. Any difference between the proceeds transferred or received and the carrying amounts of the net assets is recognized in equity in the transferring and receiving entities’ separate financial statements and eliminated in consolidation. The change in accounting principle is applied retroactively for all periods presented.

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported therein. Due to the inherent uncertainty involved in making estimates, actual results reported in future periods may be based upon amounts that differ from these estimates.

The Company considers all highly liquid investments with maturities of 90 days or less from the date of purchase to be cash equivalents.

The Company began seeing the impact of the COVID-19 pandemic on its business in early March 2020. The direct financial impact of the pandemic has primarily shown in significantly reduced production from the on-premises channel and higher labor and safety-related costs at the Company’s manufacturing facility. In addition to these direct financial impacts, COVID-19 related safety measures resulted in a reduction of manufacturing productivity. The Company will continue to assess and manage this situation and will provide a further update in each quarterly earnings release, to the extent that the effects of the COVID-19 pandemic are then known more clearly.

The Company recognizes revenue when obligations under the terms of a contract with its customer are satisfied; generally, this occurs with the transfer of control of its products. Revenue is measured as the amount of consideration expected to be received in exchange for transferring products. If the conditions for revenue recognition are not met, the Company defers the revenue and related cost of sales until all conditions are met. As of March 31, ~~2021~~2022 and December 31, ~~2020,~~2021, the Company has deferred ~~$1,530,671~~$1,518,587 and ~~$71,280,~~$1,104,923, respectively, in revenue, and ~~$238,247~~$1,053,696 and ~~$489~~$880,494 in cost of sales, respectively, related to customer orders in progress. These amounts are recorded as billings in excess of revenues and earnings in excess of billings in the accompanying balance sheets.

Accounts receivable are stated at the amount that management expects to collect from outstanding balances. Bad debts and allowances are provided based on historical experience and management’s evaluation of outstanding accounts receivable. Management evaluates past due or delinquency of accounts receivable based on the open invoices aged on due date basis. The allowance for doubtful accounts at March 31, ~~2021~~2022 and December 31, ~~2020~~2021 is $0.

Inventories consist of raw materials, work in process and finished goods. Raw materials, which principally consist of raw stainless steel, raw stainless tubing, motors, pumps, and fittings, are stated at the lower of cost, determined on the first-in, first-out basis, or net realizable value. During the year ended December 31, 2021, the Company wrote off ~~$17,246~~$39,434 in obsolete inventory to the statement of operations. As of March 31, ~~2021~~2022 and December 31, ~~2020,~~2021, the Company has inventory of ~~$68,478~~$162,908 and ~~$44,223,~~$147,859, respectively.

The excess of the cost over the fair value of net assets of acquired in the Merger is recorded as goodwill. Goodwill is not subject to amortization, but is reviewed for impairment annually, or more frequently whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. An impairment charge would be recorded to the extent the carrying value of goodwill exceeds its estimated fair value. The testing of goodwill under established guidelines for impairment requires significant use of judgment and assumptions. Changes in forecasted operations and other assumptions could materially affect the estimated fair values. Changes in business conditions could potentially require adjustments to these asset valuations.

The Company records its intangible assets at cost in accordance with ASC 350, Intangibles – Goodwill and Other. The Company reviews the intangible assets for impairment on an annual basis or if events or changes in circumstances indicate it is more likely than not that they are impaired. These events could include a significant change in the business climate, legal factors, a decline in operating performance, competition, sale, or disposition of a significant portion of the business, or other factors. If the review indicates the impairment, an impairment loss would be recorded for the difference of the value recorded and the new value. For the periods ended March 31, 2022, and December 31, 2021, there were no impairment losses recognized for intangible assets. The Company amortizes the capitalized distribution fees over a term of five years in connection with the distribution agreement.

The Company is a manufacturer of products which are shipped to our customers directly from the Company. For products that are made from raw materials, the Company offers a 6-year limited warranty. The parts provided by outside vendors as finished goods that are added to a system produced by the Company as components, have a manufacturers’ warranty that is passed on to the end user of the complete system. To date, BrewBilt has spent less than $5,000 over the past 5 years for repairs (under warranty) on products they have built, with most of the costs going to cover travel and lodging expenses. As of March 31, ~~2021~~2022 and December 31, ~~2020,~~2021, the Company has recorded a liability of ~~$5,000~~$5,000 and ~~$5,000,~~$5,000, respectively, for warranties, which is included in accrued liabilities in the accompanying balance sheet.

Accounts payable and accrued expenses are carried at amortized cost and represent liabilities for goods and services provided to the Company prior to the end of the fiscal year that are unpaid and arise when the Company becomes obliged to make future payments in respect of the purchase of these goods and services.

Fair value is defined as the price that would be received upon sale of an asset or paid upon transfer of a liability in an orderly transaction between market participants at the measurement date and in the principal or most advantageous market for that asset or liability. The fair value should be calculated based on assumptions that market participants would use in pricing the asset or liability, not on assumptions specific to the entity. In addition, the fair value of liabilities should include consideration of non-performance risk including our own credit risk.

In addition to defining fair value, the standard expands the disclosure requirements around fair value and establishes a fair value hierarchy for valuation inputs is expanded. The hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. Each fair value measurement is reported in one of the three levels, and which is determined by the lowest level input that is significant to the fair value measurement in its entirety.

Level 1 - inputs are based upon unadjusted quoted prices for identical instruments traded in active markets.

Level 2 - inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3 -– inputs are generally unobservable and typically reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability. The fair values are therefore determined using model-based techniques that include option pricing models, discounted cash flow models, and similar techniques.

In management’s opinion, the fair value of convertible notes payable and advances payable is approximate to carrying value as the interest rates and other features of these instruments approximate those obtainable for similar instruments in the current market. Unless otherwise noted, it is management’s opinion that the Company is not exposed to significant interest, exchange or credit risks arising from these financial instruments. As of March 31, ~~2021~~2022 and December 31, ~~2020,~~2021, the balances reported for cash, accounts receivable, prepaid expenses, accounts payable, and accrued liabilities, approximate the fair value because of their short maturities.

Debt issuance costs and debt discounts are being amortized over the lives of the related financings on a basis that approximates the effective interest method. Costs and discounts are presented as a reduction of the related debt in the accompanying consolidated balance sheets.

The Company records deferred taxes in accordance with FASB ASC No. 740, Income Taxes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and loss carryforwards and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect of a change in tax rules on deferred tax assets and liabilities is recognized in operations in the year of change. A valuation allowance is recorded when it is “more likely-than-not” that a deferred tax asset will not be realized.

As of the date of this filing, the Company is not current in filing their tax returns. The last return filed by the Company was December 31, 2019, and the Company has not accrued any potential penalties or interest from that period forward. The Company will need to file returns for the year ending December 31, 2021 and 2020, which is still open for examination.

In accordance with ASC Topic 280 – “Earnings Per Share”, the basic loss per common share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding. Diluted loss per common share is computed similar to basic loss per common share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive.

Although there were new accounting pronouncements issued or proposed by the FASB during the three months ~~ended~~ending March 31, ~~2021~~2022 and through the date of filing of this report, the Company does not believe any of these accounting pronouncements has had or will have a material impact on its financial position or results of operations.

The accompanying financial statements have been prepared assuming the Company will continue as a going concern. As of March 31, 2022, the Company has ~~experienced net losses to date, and it has not generated sufficient revenue~~a shareholders’ deficit of $15,989,607 since its inception, working capital deficit of $2,907,356, negative cash flows from operations, ~~to meet our operational overhead. We will need additional working capital to service debt~~ and ~~for ongoing~~has limited business operations, which raises substantial doubt about ~~our~~the Company’s ability to continue as a going concern. ~~Management~~The ability of the Company ~~is preparing a strategy~~ to meet ~~operational shortfalls which may include equity funding, short term or long-term financing or debt financing, to enable~~its commitments as they become payable is dependent on the ability of the Company to ~~reach~~obtain necessary financing or achieving a profitable level of operations. ~~Historically,~~There is no assurance the Company will be successful in achieving these goals.

The Company does not have sufficient cash to fund its desired production for the next 12 months. The Company has arranged financing and intends to utilize the cash received to cover ongoing operational expenses. The Company plans to seek additional financing if necessary, in private or public equity offering(s) to secure future funding for operations. There can be no assurance the Company will be successful in raising additional funding. If the Company is not able to secure additional funding, the implementation of the Company’s ~~sole officer and director has provided short term loans to meet working capital shortfalls. We have recently entered into~~business plan will be impaired. There can be no assurance that such additional financing ~~agreements with various third parties to meet our capital needs in fiscal 2021.~~

~~The accompanying financial statements do not include any adjustments related~~will be available to the ~~recoverability~~Company on acceptable terms or ~~classification of asset-carrying amounts or the amounts and classification of liabilities that may result should the Company be unable to continue as a going concern.~~at all.

Prepaid fees represent amounts paid in advance for future contractual benefits to be received. Contracting expenses paid in advance are recorded as a prepaid asset and then amortized to the statements of operations when services are rendered, or over the life of the contract using the straight-line method.

As of March 31, ~~2021~~2022 and December 31, ~~2020,~~2021, prepaid expenses consisted of the following:

On September 15, 2021, Bennett Buchanan was appointed to serve as a director of BrewBilt Manufacturing, Inc. In connection with Mr. Buchanan’s appointment, the Company agreed to repurchase 10,000 shares of Series A Convertible Preferred Stock from Mr. Buchanan issued to him under his Consulting Agreement dated January 1, 2021, for an aggregate purchase price of $100,000, payable in five installments of $20,000 each over the six month period following his appointment as a director. During the year ended December 31, 2021, the company recorded payments of $40,000 in connection with this agreement. It recognized $80,000 in consulting fees in 2021 and $40,000 was recognized in the first quarter of 2022.

Property and equipment consisted of the following at March 31, ~~2021~~2022 and December 31, ~~2020:~~2021:

March 31, December 31,
2021 2020
Computer Equipment $ 23,876 $ 23,876
Leasehold Improvements 59,121 59,121
Machinery 257,088 250,762
Software 23,183 17,688
Vehicles 6,717 6,717
369,985 358,164
Less accumulated amortization (3,395 ) (702 )
Less accumulated depreciation (254,380 ) (248,123 )
$ 112,210 $ 109,339

During the year ended December 31, 2021, the company recorded fixed assets additions of $276,035 and fixed asset proceeds of $90,746. Depreciation and amortization expenses of $16,325 and $45,420 were recorded to the statement of operations for the periods ended March 31, 2022 and December 31, 2021, respectively.

The Company adopted the new lease guidance effective January 1, 2019 using the modified retrospective transition approach, applying the new standard to all of its leases existing at the date of initial application which is the effective date of adoption. Consequently, financial information will not be updated, and the disclosures required under the new standard will not be provided for dates and periods before January 1, 2019. We elected the package of practical expedients which permits us to not reassess (1) whether any expired or existing contracts are or contain leases, (2) the lease classification for any expired or existing leases, and (3) any initial direct costs for any existing leases as of the effective date. We did not elect the hindsight practical expedient which permits entities to use hindsight in determining the lease term and assessing impairment. The adoption of the lease standard did not change our previously reported consolidated statements of operations and did not result in a cumulative catch-up adjustment to opening equity.

The interest rate implicit in lease contracts is typically not readily determinable. As such, the Company utilizes its incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment. In calculating the present value of the lease payments, the Company elected to utilize its incremental borrowing rate based on the remaining lease terms as of the January 1, 2019 adoption date.

Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at the commencement date. The operating lease ROU asset also includes any lease payments made and excludes lease incentives and initial direct costs incurred, if any. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Our lease has a remaining lease term of less than 4three years.

The Company has elected the practical expedient to combine lease and non-lease components as a single component. The lease expense is recognized over the expected term on a straight-line basis. Operating leases are recognized on the balance sheet as right-of-use assets, current operating lease liabilities and non-current operating lease liabilities.

The new standard also provides practical expedients and certain exemptions for an entity’s ongoing accounting. We have elected the short-term lease recognition exemption for all leases that qualify. This means, for those leases where the initial lease term is one year or less or for which the ROU asset at inception is deemed immaterial, we will not recognize ROU assets or lease liabilities. Those leases are expensed on a straight-line basis over the term of the lease.

On January 1, ~~2018,~~2020, the Company entered into a standard office lease for approximately 8,000 square feet of space, located in the Wolf Creek Industrial Building at 110 Spring Hill Dr. #10 Grass Valley, CA 95945. The lease has a term of ~~10 years, from January 1, 2018 through January 1, 2028, with a monthly rent of $4,861.~~

On January 1, 2020, the Company terminated the lease agreement dated January 1, 2018, and entered into a new office lease for the same space located in the Wolf Creek Industrial Building at 110 Spring Hill Dr. #10 Grass Valley, CA 95945. The lease has a term of 5five years, from January 1, 2020 through December 31, 2025, with a monthly rent of $4,861.

As of March 31, 2022 and December 31, 2021, ROU assets and lease liabilities related to our operating lease is as follows:

The following is a schedule, by years, of future minimum lease payments required under the operating lease:

On August 20, 2021, the company entered into an Exclusive Distribution Agreement with South Pacific Traders Oy. Pursuant to the agreement, the company will issue 50,000 Series A Convertible Preferred stock at $10 per share. South Pacific Traders will market BrewBilt Manufacturing equipment to the European Community and United Kingdom. Management determined that the 50,000 Series A Convertible Preferred to be issued as consideration for the exclusive distribution agreement is a finite-lived intangible asset and will be amortized over the five year term of the agreement. On January 17, 2022, the company issued 50,000 shares, and $500,000 was reclassified from Convertible Stock Payable to Series A Convertible Preferred Stock. During the three month period ending March 31, 2022, the company amortized $25,000 of the capitalized distribution fees to the statement of operations.

As of March 31, ~~2021~~2022 and December 31, ~~2020,~~2021, accrued liabilities were comprised of the following:

NOTE 78 – BILLINGS IN EXCESS OF REVENUE AND EARNINGS IN EXCESS OF BILLINGS

Billings in excess of revenue is related to contracted amounts that have been invoiced to customers for which remaining performance obligations must be completed before the Company can recognize the revenue. Earnings in excess of billings is related to the cost of sales associated with the customer ~~products~~jobs that are incomplete.

Changes in unearned revenue for the periods ended March 31, ~~2021~~2022 and December 31, ~~2020~~2021 were as follows:

As of March 31, ~~2021~~2022 and December 31, ~~2020,~~2021, the Company has recorded ~~$238,247~~$1,053,696 and ~~$489,~~$880,494, respectively in earnings in excess of billings for the cost of sales related to customer orders in progress.

As of March 31, ~~2021~~2022 and December 31, ~~2020,~~2021, notes payable were comprised of the following:

	Original		Original	Due	Interest	Conversion	March 31,			December 31,
	Note Amount		Note Date	Date	Rate	Rate	2022			2021
CBP #3		30,000	5/1/2020	5/1/2021	15%	Variable		9,576			9,576
CBP #4		30,000	7/23/2020	7/23/2021	15%	Variable		30,000			30,000
Emerging Corp Cap #2		110,000	10/31/2018	10/31/2019	24%	Variable		110,000			110,000
GPL Ventures #3		240,000	5/6/2021	5/6/2022	10%	0.001		—			240,000
Mammoth Corp #1		33,000	11/19/2020	8/19/2021	18%	Variable		33,000			33,000
Mammoth Corp #2		60,000	12/30/2021	12/30/2022	0%	Variable		60,000			60,000
Mammoth Corp #3		26,800	03/21/22	12/21/22	0%	Variable		26,800			—
Mast Hill Fund		550,000	10/6/2021	10/6/2022	12%	0.0015		550,000			550,000
Optempus #1		25,000	7/2/2020	7/2/2021	22%	Variable		25,000			25,000
Optempus #2		25,000	7/7/2020	7/2/2021	22%	Variable		25,000			25,000
Optempus #3		15,000	11/24/2020	11/24/2021	10%	Variable		15,000			15,000
Optempus #4		40,000	12/29/2020	12/29/2021	10%	Variable		40,000			40,000
Power Up Lending #23		43,750	8/11/2021	8/11/2022	10%	Variable		—			43,750
Power Up Lending #24		48,750	9/14/2021	9/14/2022	10%	Variable		—			48,750
Power Up Lending #25		43,750	10/8/2021	10/8/2022	10%	Variable		—			43,750
Tri-Bridge #3		25,000	1/14/2021	7/14/2021	10%	Variable		—			25,000
Tri-Bridge #4		25,000	2/24/2021	8/24/2021	10%	Variable		—			25,000
Tri-Bridge #5		240,000	5/6/2021	5/6/2022	10%	0.001		240,000			240,000
Red Road		135,000	2/25/2022	2/25/2023	10%	Variable		135,000			—
							$	1,299,376		$	1,563,826
Debt discount								(314,500	)		(527,933	)
Financing costs/Original issue discount								(67,553	)		(125,831	)
Notes payable, net of discount							$	917,323		$	910,062

During the three months ending March 31, ~~2021,~~2022, the Company received proceeds from new convertible notes of ~~$185,000.~~$158,000. The Company recorded no$66,488 in penalties, payments of $153,611 on their convertible notes and conversions of ~~$256,781~~$339,126 of convertible note principal. The Company recorded loan fees on new convertible notes of ~~$7,000,~~$3,800, which increased the debt discounts recorded on the convertible notes during the three months ending March 31, ~~2021. All~~2022. Some of the Company’s convertible notes have a conversion rate that is variable, and therefore, the Company has accounted for their conversion features as derivative instruments (see Note ~~10)~~11). The Company also recorded amortization of ~~$385,702~~$341,511 on their convertible note debt discounts and loan fees. As of March 31, ~~2021,~~2022, the convertible notes payable are convertible into ~~372,720,010~~7,750,003,778 shares of the Company’s common stock.

During the three months ended March 31, ~~2021,~~2022, the Company recorded interest expense of ~~$26,016~~$45,812 and conversions of $27,602 on its convertible notes payable. ~~During the three months ended March 31, 2021, the Company recorded conversions of $16,185 of note interest and $2,500 in conversion fees.~~ As of March 31, ~~2021,~~2022, the accrued interest balance was ~~$79,762.~~$167,312.

As of March 31, ~~2021,~~2022, we have not attained profitable operations and are dependent upon obtaining financing to pursue any extensive acquisitions and activities.

On June 19, 2020, the Company received funding pursuant to a promissory note. for $108,000 of which $93,090 was received in cash and $14,910 was recorded as transaction fees. The note bears interest of 12% (increases to 24% per annum upon an event of default) and matures on June 19, 2021. As of March 31, 2021, the company has amortized $11,642 of the financing costs to the statement of operations. As of March 31, 2021, the note has a principal balance of $108,000 and accrued interest of $10,119.

On January 5, 2021, the Company received funding pursuant to a promissory ~~note. for $50,000~~note in the amount of $50,000, of which, ~~$39,000~~$39,000 was received in cash and ~~$11,000~~$11,000 was recorded as transaction fees. The note bears interest of 12% (increases to 16% per annum upon an event of default) and matures on January 5, 2022. As of March 31, ~~2021,~~2022, the company has amortized ~~$2,562~~$11,000 of the financing costs to the statement of operations. As of March 31, ~~2021,~~2022, the note has a principal balance of ~~$50,000~~$50,000 and accrued interest of ~~$1,397.~~$7,863.

On ~~March 17,~~July 15, 2021, the Company received funding pursuant to a promissory ~~note. for $80,500~~note in the amount of $75,000, of which ~~$70,000~~$62,500 was received in cash and ~~$10,500~~$12,500 was recorded as transaction fees. The note bears interest of 12% (increases to 16% per annum upon an event of default) and matures on ~~March 17,~~July 15, 2022. As of March 31, ~~2021,~~2022, the company has amortized ~~$422~~$8,870 of the financing costs to the statement of operations. As of March 31, ~~2021,~~2022, the note has a principal balance of ~~$80,500~~$75,000 and accrued interest of ~~$371.~~$6,386.

On September 14, 2021, the Company received funding pursuant to a promissory note in the amount of $100,000, of which, $82,500 was received in cash and $17,500 was recorded as transaction fees. The note bears interest of 12% (increases to 16% per annum upon an event of default) and matures on September 14, 2022. As of March 31, 2022, the company has amortized $9,493 of the financing costs to the statement of operations. As of March 31, 2022, the note has a principal balance of $100,000 and accrued interest of $6,510.

During the three months ended March 31, ~~2021,~~2022, the Company valued the embedded conversion feature of the convertible notes and warrants. The Company uses the Black-Scholes option pricing model to estimate fair value for those instruments convertible into common shares at inception, at conversion or extinguishment date, and at each reporting date.

The following table represents the Company’s derivative liability activity for the embedded conversion features for the three months ended March 31, ~~2021:~~

The fair value at the commitment date for the convertible notes ~~and warrants~~ and the revaluation dates for the Company’s derivative liabilities were based upon the following management assumptions as of March 31, ~~2021:~~2022:

We account for common stock purchase warrants as derivative liabilities and debt issuance costs on the balance sheet at fair value, and changes in fair value during the periods presented in the statement of operations, which is revalued at each balance sheet date subsequent to the initial issuance of the warrant.

On June 19, 2020, the Company executed a Common Stock Purchase Warrant for 5,400,000 shares. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price of $0.02 per share and expire on June 19, 2025.

On July 23, 2020, the Company executed a Common Stock Purchase Warrant for 1,153,846 shares. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price of $0.026 per share and expire on July 23, 2025.

On August 19, 2020, the Company executed a Common Stock Purchase Warrant for 5,650,000 shares. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price of $0.02 per share and expire on August 19, 2025.

On January 5, 2021, the Company executed a Common Stock Purchase Warrant for 25,000,000 shares. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price of $0.002 per share and expire on January 5, 2026.

During the three months ended March 31, 2021, warrant holders exercised the warrants and the Company issued 72,048,517 shares of common stock through a cashless exercise of the warrants in accordance with the conversion terms.

~~The Company evaluated all outstanding warrants to determine whether these instruments may be tainted. All warrants outstanding were considered tainted.~~

The fair value at the ~~valuation~~commitment date for the warrants and the revaluation dates for the Company’s derivative liabilities were based upon the following management ~~assumptions:~~assumptions as of March 31, 2022:

The following table summarizes information with respect to the outstanding warrants to purchase common stock of the Company, all of which were exercisable as of March 31, 2022:

A summary of warrant activity for the three months ended March 31, 2022 is as follows:

The aggregate intrinsic value in the preceding tables represents the total pre-tax intrinsic value, based on options with an exercise price that is higher than the Company’s market stock price of $0.0001 on March 31, 2022.

~~Mr. Jef Lewis, Chief Executive Officer, Chairman of the Board, President, Secretary, and Treasurer~~Consulting Agreements

On November 22, 2019, the Company appointed Jeffrey Lewis as the new Chief Executive Officer, Chairman of the Board, Corporate President, Secretary, and Treasurer of the Company. The Company and Mr. Lewis entered into an Employee Agreement that included the issuance of 1,000 Preferred Series B Control Shares, and an annual salary of $200,000. Unpaid wages will accrue interest at 6% per annum and may be converted to restricted common stock at fair market value at the time of conversion. During the three months ended March 31, 2021, the Company accrued wages of $50,000, interest of $1,445 and made payments of $74,344. As of March 31, 2021, the Company owed Mr. Lewis $68,025 in accrued wages and $6,401 in accrued interest.

The Company is periodically advanced noninterest bearing operating funds from related parties. The advances are due on demand and unsecured. As of March 31, 2021 and December 31, 2020, the Company owed Mr. Lewis $743 and $743, respectively for advances to the Company.

~~On November 22,~~June 19, 2019, the Company entered into a Consulting Agreement with Mr. Samuel Berry. The agreement is for a term of one year and is renewable upon mutual consent. Mr. Berry will receive an annual salary of ~~$50,000,~~$50,000, payable in quarterly installments at ~~$12,500~~$12,500 per quarter. As of December 31, 2021, Mr. Berry had an unpaid balance of $118,167. During the three months ended March 31, ~~2021,~~2022, the Company accrued ~~$50,000~~$12,500 in ~~consulting~~ fees and made ~~$5,000~~$15,000 in payments in connection to his agreement. As of March 31, ~~2021,~~2022, the Company owed Mr. Berry ~~$125,667~~$115,667 in fees.

On January 1, 2021, the Company entered into a Consulting Agreement with Bennett Buchanan to assist with marketing, advertising, customer relations, and licensing and compliance regulatory requirements. The term of the Agreement is for two years and may be terminated or extended upon mutual agreement of both parties pursuant with a thirty-day written notice. The Company will pay the Consultant a monthly fee of $3,000 and $100,000 in Series A Stock during the term of the agreement.

On November 1, 2021, the parties agreed to terminate the agreement dated January 1, 2021 and entered into a new Consulting Agreement. The term of the Agreement is for two years and may be terminated or extended upon mutual agreement of both parties pursuant with a thirty-day written notice. The Company agreed to pay the Consultant a monthly fee of $3,000 and $100,000 in Convertible Preferred Series A stock.

On January 1, 2022, the Company entered into a Directors Agreement with Jef Lewis for a term of one year. In exchange for serving in this capacity, the Company will issue 5,000 shares of Convertible Preferred Series A stock at a price of $10 per share. The shares are restricted and cannot be sold or otherwise transferred by the undersigned except as provided by law, and in no event, prior to the maturity date of six (6) months.

On January 1, 2022, the Company entered into a Directors Agreement with Sam Berry for a term of one year. In exchange for serving in this capacity, the Company will issue 5,000 shares of Convertible Preferred Series A stock at a price of $10 per share. The shares are restricted and cannot be sold or otherwise transferred by the undersigned except as provided by law, and in no event, prior to the maturity date of six (6) months.

On January 1, 2022, the Company entered into a Directors Agreement with Bennett Buchanan for a term of one year. In exchange for serving in this capacity, the Company will issue 5,000 shares of Convertible Preferred Series A stock at a price of $10 per share. The shares are restricted and cannot be sold or otherwise transferred by the undersigned except as provided by law, and in no event, prior to the maturity date of six (6) months.

As of March 31, ~~2021~~2022 and December 31, ~~2020,~~2021, long term debt was comprised of the following:

~~On May 11, 2020, the Company was granted a loan (the “Loan”) from BSD Capital, LLC dba Lendistry, in the amount~~Schedule of ~~$61,558, pursuant to the Paycheck Protection Program (the “PPP”) under Division A, Title I of the CARES Act, which was enacted March 27, 2020.~~Long Term Debt

The Loan, which was in the form of a Note dated May 11, 2020, issued by the Borrower, matures on May 11, 2022, and bears interest at a rate of 1% per annum, payable monthly commencing on November 11, 2020. The Note may be prepaid by the Borrower at any time prior to maturity with no prepayment penalties. Funds from the Loan may only be used for payroll costs, costs used to continue group health care benefits, mortgage payments, rent, utilities, and interest on other debt obligations. The Company intends to use the entire Loan amount for qualifying expenses. Under the terms of the PPP, certain amounts of the Loan may be forgiven if they are used for qualifying expenses as described in the CARES Act.

In August 2021, the Company returned $96,357 in equipment to the lender to settle debt of $74,480, and a loss on disposal of assets of $16,267 was recorded to the statement of operations.

~~On March 28, 2017, the Company filed an amendment to its articles of incorporation designating 20,000 shares of its authorized preferred stock, par value $0.001 as~~ Series ~~B Voting Preferred Stock. The Series B Voting~~A Convertible Preferred Stock shall have the right to vote the shares on any matter requiring shareholder approval on the basis of 4 times the votes of all the issued and outstanding shares of common stock, as well as any issued and outstanding preferred stock.

On July 1, 2019, the Company filed a Certificate of Amendment to increase the number of authorized Series A Convertible Preferred Stock to 30,000,000, with a par value of ~~$0.001.~~$0.001. Each share of Convertible Preferred Series A Stock shall have a value of $10 per share and will convert into common stock at the closing price of the common stock on the date of conversion. The Series A stock shall have no voting rights on corporate matters, unless and until the Series A shares are converted into Common Shares, at which time they will have the same voting rights as all Common Shareholders have; their consent shall not be required for taking any corporate action.

Pursuant to the Merger Agreement dated November 22, 2019, the Company ~~will issue~~issued $5,000,000 worth of Convertible Preferred Series A Stock to Mr. Lewis. The number of Convertible Preferred Series A shares to be issued is 500,000 shares at a price of ~~$10.00~~$10 per share and convertible pursuant the conversion rights as specified in the Articles of Incorporation and Certificate of Designation for the Company. As of December 31, 2019, the shares had not been issued, and the Company recorded a liability for unissued shares in the amount of $500, goodwill of $2,289,884 and $2,289,334 to additional paid in capital.

On March 1, 2020, 500,000 shares of Convertible Preferred Series A Shares were issued pursuant to the Merger ~~Agreement, and a $500 liability for unissued shares was reclassed to equity.~~Agreement.

On April 6, 2020, the Company executed an addendum to the Distribution & Licensing Agreement dated November 19, 2019, with Bgreen Partners, ~~Inc.~~Inc. The Company issued 400,000 Convertible Preferred Series A shares at a price of ~~$10.00~~$10 per share which are convertible pursuant the conversion rights as specified in the Articles of Incorporation and certificate of designation for the Company.

On October 15, 2020, the Company entered into an IP Purchase and License Agreement with Maguire & Associates, LLC in the amount of $5,000,000. The Company issued 500,000 Convertible Preferred Series A shares at a price of ~~$10.00~~$10 per share which are convertible pursuant the conversion rights as specified in the Articles of Incorporation and certificate of designation for the Company.

On November 20, 2020, Mr. Lewis converted 70,000,000 common shares at a price of $.0018 per share into 54,000 Convertible Preferred Series A Shares at a price of $10 per share. The conversion resulted in a loss of $414,000 which was recorded to the statement of operations.

During the year ended December 31, 2020, 734,000 shares of Series A Convertible Preferred stock were converted to 2,416,667,054 common shares in accordance with the conversion terms. The issuances resulted in a loss on conversion of $1,572,272 which was recorded to the statement of operations.

On January 1, 2021, the Company issued 10,000 shares of Series A Convertible Preferred stock at $10 per share to Bennett Buchanan, pursuant to his Consulting Agreement dated January 1, 2021.

On April 13, 2021, the Company issued 10,000 shares of Series A Convertible Preferred stock to key employee Corbin Boyle at $10 per share.

On April 13, 2021, the Company issued 10,000 shares of Series A Convertible Preferred stock to key employee Jesse Prim at $10 per share.

On May 14, 2021, the Company issued 14,497 shares of Series A Convertible Preferred stock at $10 per share, to settle liabilities of $144,970.

On September 15, 2021, the Company repurchased 10,000 shares of Series A Convertible Preferred stock at $10 per share from Bennett Buchanan, pursuant to his Director Agreement. The shares were purchased for $100,000, which is payable in five installments of $20,000 each over the six-month period following his appointment as a director.

On December 1, 2021, the Company issued 10,000 shares of Series A Convertible Preferred stock at $10 per share to Bennett Buchanan, pursuant to his Consulting Agreement dated November 1, 2021.

On December 8, 2021, the Company issued 500,000 shares of Series A Convertible Preferred stock at $10 per share to Jef Lewis, pursuant to his Employment Agreement dated October 1, 2021.

On December 27, 2021, the Company issued 100,000 of Preferred Series A shares to Mr. Berry for his four years of service as a Director for the company.

During the ~~three months~~year ended ~~March~~December 31, 2021, ~~172,500~~434,780 shares of Convertible Series A Preferred stock were converted to ~~570,299,494~~2,675,120,601 common shares in accordance with the conversion terms. The issuances resulted in a loss on conversion of ~~$786,315~~$2,657,807, which was recorded to the statement of operations.

On March 2, 2022, the Company issued 5,000 shares of Series A Convertible Preferred stock to key employee Andrew Salo at $10 per share.

On March 4, 2022, the Company issued 2,500 shares of Series A Convertible Preferred stock for advertising services provided by Jef Freeman at $10 per share.

During the three months ended March 31, 2022, 23,720 shares of Convertible Series A Preferred stock were converted to 908,980,057 common shares in accordance with the conversion terms. The issuances resulted in a loss on conversion of $121,557, which was recorded to the statement of operations.

The Series A Convertible Preferred Stock has been classified outside of permanent equity and liabilities since it embodies a conditional obligation that the Company may settle by issuing a variable number of equity shares and the monetary value of the obligation is based on a fixed monetary amount known at inception. Each share of the Convertible Series A Preferred Stock has a fixed value of $10 per share, has no voting rights, and is convertible into common stock at closing market price on the date of conversion. The Company has recorded $13,634,970, which represents 1,363,497 Series A Convertible Preferred Stock at $10 per share, issued and outstanding as of March 31, 2022, outside of permanent equity and liabilities.

On August 20, 2021, the company agreed to issue 50,000 Convertible Preferred Series A shares at $10 per share to South Pacific Traders Oy pursuant to an exclusive distribution agreement. The shares were issued on January 17, 2022 and $5,000,000 was reclassified to Series A Convertible Preferred Stock.

On January 1, 2022, the company agreed to issue 5,000 Convertible Series A shares at $10 per share to Jef Lewis, Sam Berry, and Bennett Buchanan, pursuant to Directors Agreements.

On March 28, 2017, the Company filed an amendment to its articles of incorporation designating 20,000 shares of its authorized preferred stock, par value $0.001 as Series B Voting Preferred Stock. The Series B Voting Preferred Stock shall have the right to vote the shares on any matter requiring shareholder approval on the basis of 4 times the votes of all the issued and outstanding shares of common stock, as well as any issued and outstanding preferred stock.

On November 22, 2019, President Jef Lewis was issued 1,000 Preferred Series B Control Shares, pursuant to his employee agreement dated November 22, 2019.

As of March 31, ~~2021, 30,000,000 Series A Preferred shares and~~ 2022, 1,000 Series B Preferred shares were authorized, of which ~~957,500 Series A shares were issued and outstanding, and~~ 1,000 Series B shares were issued and outstanding.

On April 22, 2019, the Company approved the authorization of a 1 for 3,000 reverse stock split of the Company’s outstanding shares of common stock. The Company’s financial statements have been retroactively adjusted for this stock split for all periods presented.

During the year ended December 31, 2019, the holder of a convertible note converted $1,148 of accrued interest and $500 in conversion fees into 400,000 shares of common stock. The common stock was valued at $5,077 based on the market price of the Company’s stock on the date of conversion.

On March 17, 2020, the Company’s former President cancelled 8,008,334 shares of common stock issued to settle debt of $25,342 and $25,000 in stock based compensation pursuant to an employee agreement. The cancellation resulted in a liability of unissued shares of $25,000 and an increase in related party liabilities of $25,342. On December 31, 2020, Mr. Rushford agreed to forgive the debt and ~~$50,342~~$50,342 was recorded to additional paid in capital.

On March 25, 2020, the Company filed a Certificate of Amendment to increase the number of authorized common shares from 5,000,000,000 to 10,000,000,000 with a par value of ~~$0.001.~~$0.001.

On December 4, 2020, the Company filed a Certificate of Amendment to increase the number of authorized common shares from 10,000,000,000 to 20,000,000,000 with a par value of ~~$0.001.~~$0.001.

During the year ended December 31, 2020, the holders of a convertible notes converted $1,388,809 of principal, $351,376 of accrued interest and $39,275 in conversion fees into 1,023,817,685 shares of common stock. The common stock was valued at ~~$8,141,166~~$8,141,166 based on the market price of the Company’s stock on the date of conversion.

On June 10, 2021, the Company filed a Certificate of Amendment to increase the number of authorized common shares from 20,000,000,000 to 25,000,000,000 with a par value of $0.001.

During the ~~three months~~year ended ~~March~~December 31, 2021, warrant holders exercised the warrants and the Company issued ~~72,048,517~~386,006,850 shares of common stock through a cashless exercise of the warrants in accordance with the conversion terms.

During the ~~three months~~year ended ~~March~~December 31, 2021, the holders of a convertible notes converted ~~$256,781~~$984,042 of principal, ~~$16,185~~$78,686 of accrued interest and ~~$2,500~~$7,750 in conversion fees into ~~175,060,588~~1,316,251,353 shares of common stock. The common stock was valued at ~~$1,623,336~~$3,768,693 based on the market price of the Company’s stock on the date of conversion.

During the year ended December 31, 2021, the holder 1,316,251,353 of a promissory notes converted $108,000 of principal, $12,960 of accrued interest, $15,000 in penalties, and $750 in conversion fees into 198,130,434 shares of common stock. The common stock was valued at $594,391 based on the market price of the Company’s stock on the date of conversion.

During the three months ended March 31, 2022, the holders of a convertible notes converted $339,126 of principal and $27,602 of accrued interest into 3,784,719,901 shares of common stock. The common stock was valued at $1,342,016 based on the market price of the Company’s stock on the date of conversion.

As of March 31, ~~2021, 20,000,000,000~~2022, 25,000,000,000 were authorized, of which ~~4,351,431,054~~12,803,231,651 shares are issued and outstanding.

Deferred income taxes are determined using the liability method for the temporary differences between the financial reporting basis and income tax basis of the Company’s assets and liabilities. Deferred income taxes are measured based on the tax rates expected to be in effect when the temporary differences are included in the Company’s tax return. Deferred tax assets and liabilities are recognized based on anticipated future tax consequences attributable to differences between financial statement carrying amounts of assets and liabilities and their respective tax bases.

The deferred tax asset and the valuation allowance consist of the following at March 31, ~~2021:~~2022:

On January 1, 2020, the Company entered into a new office lease for space located in the Wolf Creek Industrial Building at 110 Spring Hill Dr. #10 Grass Valley, CA ~~95945.~~95945. The lease has a term of 5 years, from January 1, 2020 through December 31, 2025, with a monthly rent of ~~$4,861.~~$4,861.

On June 12, 2018, the Company entered into a preventative maintenance service agreement with Atlas Copco Compressions LLC. The agreement is for a period of 5 years, at a cost of $145.13 per month.

On April ~~6, 2021, 7,500 shares~~28, 2022, the Company approved the authorization of ~~Preferred Series A~~a 1 for 300 reverse stock ~~was converted into 50,000,000~~split of the Company’s outstanding shares of common stock. In addition, the Company reduced the number of authorized shares from 25,000,000,000 to 83,333,333 shares with a par value of $0.001.

On April ~~13, 2021, 10,000 shares~~29, 2022, the Company entered into a Promissory Note in the amount of ~~Preferred Series A stock was issued to employee Jesse Prim~~$53,750. The note is unsecured, bears interest at ~~$10~~10% per ~~share.~~annum, and matures on April 29, 2023.

~~On April 13, 2021, 10,000 shares of Preferred Series A stock was issued to employee Corbin Boyle at $10 per share.~~

~~On April 15, 2021, 18,900 shares of Preferred Series A stock was converted into 60,000,000 shares of common stock.~~

~~On April 15, 2021, the holder of a convertible note converted a total of $45,150 of principal and interest into 19,630,435 shares of our common stock.~~

~~On April 19, 2021, 15,000 shares of Preferred Series A stock was converted into 125,000,000 shares of common stock.~~

~~On April 28, 2021, the holder of a convertible note converted a total of $54,123 of principal, interest, and fees into 29,161,255 shares of our common stock.~~

The Company has evaluated subsequent events pursuant to ASC Topic 855 and has determined that there are no additional subsequent events to disclose.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION

The following discussion and analysis summarizes the significant factors affecting our consolidated results of operations, financial condition, and liquidity position for the three and three months ended March 31, ~~2021.~~2022. This discussion and analysis should be read in conjunction with our audited financial statements and notes thereto included in our Annual Report on Form 10-K for our year-ended December 31, ~~2020~~2021 and the consolidated unaudited financial statements and related notes included elsewhere in this filing. The following discussion and analysis contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements.

This quarterly report contains forward-looking statements relating to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may”, “should”, “intends”, “expects”, “plans”, “anticipates”, “believes”, “estimates”, “predicts”, “potential”, or “continue” or the negative of these terms or other comparable terminology. These statements are only predictions and involve known and unknown risks, uncertainties and other factors which may cause our or our industry’s actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements.

Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity or performance. You should not place undue reliance on these statements, which speak only as of the date that they were made. These cautionary statements should be considered with any written or oral forward-looking statements that we may issue in the future. Except as required by applicable law, including the securities laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements to actual results, later events, or circumstances or to reflect the occurrence of unanticipated events.

In this report unless otherwise specified, all dollar amounts are expressed in United States dollars and all references to “common shares” refer to the common shares of our capital stock.

The management’s discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”).

As used in this quarterly report, the terms “we”, “us”, “our”, and “our company” means BrewBilt Manufacturing, Inc., unless otherwise indicated.

Results for the Three Months Ended March 31, ~~2021~~2022 Compared to the Three Months Ended March 31, ~~2020~~2021

The Company’s revenues were $11,300 for the three months ended March 31, 2022 compared to $13,251 for the three months ended March 31, ~~2021 compared to $38,934 for the three months ended March 31, 2020.~~2021. The decrease is due to fewer projects being completed and delivered to customers in Q1 ~~2021. In addition, the average revenue per job for the customer orders that were completed were lower in Q1 2021 compared to Q1 2020.~~2022.

The Company’s cost of materials was $5,773 for the three months ended March 31, 2022, compared to $7,614 for the three months ended March 31, ~~2021, compared to $21,623 for the three months ended March 31, 2020.~~2021. The decrease is due to fewer completed jobs in Q1 2021.

Operating expenses consisted primarily of consulting fees, professional fees, salaries and wages, office expenses and fees associated with preparing reports and SEC filings relating to being a public company. Operating expenses for the three months ended March 31, ~~2021,~~2022, and March 31, ~~2020,~~2021, were ~~$404,001~~$601,781 and ~~$302,492,~~$404,001, respectively. The increase is ~~primarily attributable~~due to an increase in ~~consulting fees~~salaries and ~~professional fees.~~wages and general and administrative expenses.

Other ~~income (expense)~~expense for the three months ended March 31, ~~2021~~2022 and March 31, ~~2020~~2021 was ~~$(2,239,394)~~$1,477,835 and ~~$(1,851,208),~~$2,239,394, respectively. Other income (expense) consisted of losses on derivative valuation, losses on conversion on preferred stock to common stock and interest expense. The gain or loss on derivative valuation is directly attributable to the change in fair value of the derivative liability. Interest expense is primarily attributable the initial interest expense associated with the valuation of derivative instruments at issuance and the accretion of the convertible debentures over their respective terms. The ~~variance~~decrease primarily resulted from ~~an increase in interest expense~~the fluctuation of the Company’s stock price which impacted the valuation of the derivative liabilities on the convertible debt and a decrease in loss on ~~conversion of Preferred~~ Series A ~~stock to common stock.~~conversions.

Net loss for the three months ended March 31, ~~2021~~2022 was ~~$2,637,758~~$2,074,089 compared with ~~$2,136,389~~$2,637,758 for the three months ended March 31, ~~2020.~~2021. The ~~increased~~decreased loss can be explained by ~~and increase~~the gain on the change in ~~operating expenses, interest expenses~~fair value of derivative liabilities and a decreased loss on ~~conversion of Preferred Series A~~preferred stock ~~to common stock.~~conversions.

~~We believe that the rate of inflation has had a negligible effect on our operations.~~

The accompanying financial statements have been prepared assuming the Company will continue as a going concern. As of March 31, ~~2021,~~2022, the Company ~~had $379,857~~has a shareholders’ deficit of $15,989,607 since its inception, working capital deficit of $2,907,356, negative cash flows from operations, and ~~$1,972,415~~has limited business operations, which raises substantial doubt about the Company’s ability to continue as going concern. The ability of the Company to meet its commitments as they become payable is dependent on the ability of the Company to obtain necessary financing or achieving a profitable level of operations. There is no assurance the Company will be successful in ~~cash and total assets, as well as $5,834,625 in total liabilities as compared to $72,764 and $597,016 in cash and total assets, and $4,766,420 in total liabilities as of~~achieving these goals.

The overall working capital (deficit) decreased from $(3,085,906) at December 31, ~~2020. The increase in working capital is~~2021 to $(2,907,356) at March 31, 2022 due to an increase in ~~cash on hand due to funds from notes payable,~~raw material purchases and ~~an increase~~a decrease in ~~accounts receivable for new sales closed in Q1 2021.~~derivative liabilities and accrued liabilities.

The Company requires additional capital to fully execute its marketing program and increase revenues. Presently we are relying on short term loans from our sole officer and director to meet operational shortfalls. There can be no assurance that continued funding will be available on satisfactory terms. We intend to raise additional capital through the sale of equity, loans or other short-term financing options.

During the three months ended March 31, ~~2021,~~2022, cash from (used in) operating activities was ~~$127,182~~$(166,057) compared to ~~$(235,892)~~$125,420 for the three months ended March 31, ~~2020.~~2022. The variance primarily resulted from ~~increases~~the change in ~~amortization~~fair value of ~~debt discounts, losses on conversions, share based compensation~~derivative liabilities, and ~~billings~~a decrease in ~~excess of revenues~~operating assets during the three months ended March 31, ~~2021.~~2022.

During the three months ended March 31, ~~2021~~2022, cash from (used in) investing activities was ~~$(11,821)~~$0 compared to ~~$12,403~~$(11,821) for the three months ended March 31, ~~2020.~~2021. The variance in cash from (used in) investing activity is due to a decrease in fixed assets ~~purchased~~purchases in the ~~first quarter 2021.~~three months ended March 31, 2022.

During the three months ended March 31, ~~2021~~2022, cash from ~~(used in)~~ financing activities was ~~$191,732~~$20,114 compared to ~~$222,665~~$193,494 for the three months ended March 31, ~~2020.~~2021. The ~~variance~~decrease in cash from financing activity is due to a decrease in proceeds from convertible debt and payments made to convertible debt during the ~~change in related party liabilities.~~three months ended March 31, 2022.

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

We have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to stockholders.

The preparation of our financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an on-going basis, management evaluates its estimates and judgments which are based on historical experience and on various other factors that are believed to be reasonable under the circumstances. The results of their evaluation form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ from these estimates under different assumptions and circumstances. Our significant accounting policies are more fully discussed in the Notes to our Financial Statements, included herein.

A smaller reporting company is not required to provide the information required by this Item.

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports filed under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including our president and chief financial officer (our principal executive officer, principal financial officer and principal accounting officer) to allow for timely decisions regarding required disclosure.

As of the end of the quarter covered by this report, we carried out an evaluation, under the supervision and with the participation of our president and chief financial officer (our principal executive officer, principal financial officer, and principal accounting officer), of the effectiveness of the design and operation of our disclosure controls and procedures. Based on the foregoing, our president and chief financial officer (our principal executive officer, principal financial officer, and principal accounting officer) concluded that our disclosure controls and procedures were not effective as of the end of the period covered by this quarterly report. Our company is in the process of adopting specific internal control mechanisms to ensure effectiveness as we grow, and we will work to retain additional qualified individuals to ensure a proper segregation of duties. We have engaged an outside consultant to assist in adopting new measures to improve upon our internal controls. Future controls, among other things, will include more checks and balances and communication strategies between the management and the board, once we are able to secure additional board members, to ensure efficient and effective oversight over company activities as well as more stringent accounting policies to track and update our financial reporting.

There were no changes in our internal control over financial reporting during the quarterly period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

We know of no material, existing or pending legal proceedings against us, nor are we involved as a plaintiff in any material proceeding or pending litigation. There are no proceedings in which any of our directors, officers, or affiliates, or any registered or beneficial shareholder, is an adverse party or has a material interest adverse to our company.

A smaller reporting company is not required to provide the information required by this Item.

On January ~~1, 2021,~~17, 2022, the Company issued ~~10,000~~50,000 shares of Convertible Preferred Series A stock, valued at $5,000,000 to South Pacific Traders Oy pursuant to an exclusive distribution agreement.

On March 2, 2022, the Company issued 5,000 shares of Series A Convertible Preferred stock to ~~Bennett Buchanan pursuant to his Consulting Agreement.~~key employee Andrew Salo at $10 per share.

On March 4, 2022, the Company issued 2,500 shares of Series A Convertible Preferred stock for advertising services provided by Jef Freeman at $10 per share.

During the three months ended March 31, ~~2021, 172,500~~2022, 23,720 shares of Convertible Series A Preferred stock were converted to ~~570,299,494~~908,980,057 common shares in accordance with the conversion terms. The issuances resulted in a loss on conversion of ~~$786,315~~$121,557, which was recorded to the statement of operations.

During the three months ended March 31, ~~2021, warrant holders exercised the warrants and the Company issued 72,048,517 shares of common stock through a cashless exercise of the warrants in accordance with the conversion terms.~~

~~During the three months ended March 31, 2021,~~2022, the holders of a convertible notes converted ~~$256,781~~$339,126 of principal ~~$16,185~~and $27,602 of accrued interest ~~and $2,500 in conversion fees~~ into ~~175,060,588~~3,784,719,901 shares of common stock. The common stock was valued at ~~$1,623,336~~$1,342,016 based on the market price of the Company’s stock on the date of conversion.

In respect of the aforementioned convertible loan agreement(s) and the underlying shares, as well as shares issued to a director and consultant, the Company will claim an exemption from the registration requirements of the Securities Act of 1933, as amended, for the issuance of the shares pursuant to Section 4(2) of the Act and/or Rule 506 of Regulation D promulgated thereunder since, among other things, the transaction does not involve a public offering, the purchasers are “accredited investors” and/or qualified institutional buyers, the purchasers have access to information about the Company and its purchase, the purchasers will take the securities for investment and not resale.

Other than as disclosed above, there were no unregistered securities to report which were sold or issued by the Company without the registration of these securities under the Securities Act of 1933 in reliance on exemptions from such registration requirements, within the period covered by this report, which have not been previously included in a Quarterly Report on Form 10-Q or a Current Report on Form 8-K.

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Florida				47-0990750
(State or other jurisdiction of incorporation)				(I.R.S. Employer Identification No.)


Large accelerated filer o	Accelerated filer o
Non-accelerated ~~filer~~ Filero (Do not check if a smaller reporting company)	Smaller reporting company x
	Emerging growth company x

		Page
	PART I – FINANCIAL INFORMATION

Item 1.	Financial Statements	3

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	2123

Item 3.	Quantitative and Qualitative Disclosure about Market Risk	2425

Item 4.	Controls and Procedures	2426

	PART II – OTHER INFORMATION

Item 1.	Legal Proceedings	2426

Item 1A.	Risk Factors	2426

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	2526

Item 3.	Defaults Upon Senior Securities	2527

Item 4.	Mine Safety Disclosures	2527

Item 5.	Other Information	2527

Item 6.	Exhibits	2627

	SIGNATURES	2728

		Page
Balance Sheets (Unaudited)		4
Statements of Operations and Comprehensive Loss (Unaudited)		5
Statements of Shareholders’ Deficit (Unaudited)		6
Statements of Cash Flows (Unaudited)		7
Notes to Financial Statements	~~8-20~~	8-22


	Three months ended						Three months ended
	March 31,						March 31,
	2021			2020			2022			2021
Sales	$	13,251		$	38,934		$	11,300		$	13,251
Cost of sales		7,614			21,623			5,773			7,614
Gross profit		5,637			17,311			5,527			5,637

Operating expenses:
Consulting fees		121,608			24,750			77,500			121,608
Depreciation and amortization								16,325			8,950
G&A expenses		150,525			82,712			161,760			141,575
Professional fees		80,702			47,370			24,294			80,702
Salaries and wages		51,166			147,660			321,902			51,166
Total operating expenses		404,001			302,492			601,781			404,001

Loss from operations		(398,364	)		(285,181	)		(596,254	)		(398,364	)

Other income (expense):
Other income								1			—
Debt forgiveness		13,924			—			—			13,924
Gain (loss) on derivative liability valuation		(1,033,712	)		(1,710,732	)
Loss on conversion		(786,315	)		—
Derivative expenses								90,828			(1,033,712	)
Loss on conversion of debt								(975,288	)		—
Loss on Series A conversion								(121,557	)		(786,315	)
Interest expense		(433,291	)		(140,476	)		(471,819	)		(433,291	)
Total other expenses		(2,239,394	)		(1,851,208	)		(1,477,835	)		(2,239,394	)

Net loss before income taxes		(2,637,758	)		(2,136,389	)		(2,074,089	)		(2,637,758	)
Income tax expense		—			—			—			—
Net loss	$	(2,637,758	)	$	(2,136,389	)	$	(2,074,089	)	$	(2,637,758	)

Per share information

Weighted number of common shares outstanding, basic, and diluted		3,996,863,319			34,595,672
Net income (loss) per common share	$	(0.0007	)	$	(0.0618	)
Weighted number of common shares outstanding, basic and diluted								10,805,715,419			3,996,863,319
Net loss per common share							$	(0.0002	)	$	(0.0007	)

	Input	March 31, 2021		December 31, 2020
	Level	Fair Value		Fair Value
Derivative Liability	3	$	1,935,295	$	2,373,176
Total Financial Liabilities		$	1,935,295	$	2,373,176

	Input		March 31, 2022		December 31, 2021
	Level		Fair Value		Fair Value
Derivative Liability		3	$	336,167	$	882,706
Total Financial Liabilities			$	336,167	$	882,706

Years Ending
December 31,	Operating Lease
2021	$	43,751
2022		58,334
2023		58,334
2024		58,334
2025		58,335
Total		277,088
Less imputed interest		40,594
Total liability	$	236,494

	Notes			Warrants			Total
Balance, beginning of period	$	2,311,296		$	61,880		$	2,373,176
Initial recognition of derivative liability		1,233,308			126,577			1,359,885
Derivative settlements		(1,437,337	)		(345,833	)		(1,783,170	)
Loss (gain) on derivative liability valuation		(551,954	)		537,358			(14,596	)
Balance, end of period	$	1,555,313		$	379,982		$	1,935,295

	Valuation date
Expected dividends		0%
Expected volatility	~~187.64%~~	116.60% - ~~341.60%~~264.64%
Expected term	~~.12~~	.01 - ~~1 year~~.75 years
Risk free interest	~~.01%~~	.02% - ~~.18%~~1.40%

Exercise Price		Number Outstanding		Expiration Date
$	0.0300		51,906	June 19, 2022
$	0.0200		5,400,000	June 18, 2025
$	0.0260		1,153,846	July 23, 2025
$	0.0200		5,650,000	August 19, 2025
$	0.0200		5,650,000	August 19, 2025
$	0.0020		25,000,000	January 5, 2026
$	0.0020		25,000,000	January 5, 2026
$	0.0020		37,500,000	July 15, 2026
$	0.0020		37,500,000	July 15, 2026
$	0.0020		50,000,000	September 14, 2026
$	0.0020		50,000,000	September 14, 2026
			242,905,752

					Weighted-Average
			Weighted-Average		Remaining		Aggregate
Warrants	Shares		Exercise Price		Contractual Term		Intrinsic Value
Outstanding at December 31, 2021		242,905,752	$	0.0034		4.43	$	—
Granted		0		—
Exercised		0		—
Forfeited or expired		0		—
Outstanding at March 31, 2022		242,905,752	$	0.0034		4.18	$	—
Exercisable at March 31, 2022		242,905,752		0.0034		4.18	$	—

	March 31,
	2021
Net operating loss	$	811,261
Statutory rate		21	%
Expected tax recovery		170,365
Change in valuation allowance		(170,365	)
Income tax provision	$	—

Components of deferred tax asset:
Non-capital tax loss carry-forwards		170,365
Less: valuation allowance		(170,365	)
Net deferred tax asset	$	—

	March 31, 2021			March 31, 2020			March 31, 2022			March 31, 2021
	$			$			$			$
Cash Flows from (used in) Operating Activities		127,182			(235,892	)		(166,057	)		125,420
Cash Flows from (used in) Investing Activities		(11,821	)		12,403			—			(11,821	)
Cash Flows from (used in) Financing Activities		191,752			222,665			20,114			193,494
Net Increase (decrease) in Cash During Period		307,093			(824	)		(145,943	)		307,093

Exhibit Number		~~Description~~
Exhibit Number		Description
31.1		Certification of the Chief Executive Officer required under Rule 13a-14(a)/15d-14(a) of the Exchange Act*
31.2		Certification of the Chief Financial Officer required under Rule 13a-14(a)/15d-14(a) of the Exchange Act*
32.1		Certification of the Chief Executive Officer and Chief Financial Officer required under Section 1350 of the Exchange Act*
101.INS		XBRL Instance Document*
101.SCH		XBRL Taxonomy Extension Schema*
101.CAL		XBRL Taxonomy Extension Calculation Linkbase*
101.DEF		XBRL Taxonomy Extension Definition Linkbase*
101.LAB		XBRL Taxonomy Extension Label Linkbase*
101.PRE		XBRL Taxonomy Extension Presentation Linkbase*

	BrewBilt Manufacturing Inc.

Date: May ~~14, 2021~~16, 2022	By: /s/ Jef Lewis

	Chief Executive Officer